BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21673032)

  • 1. Effects of hepatitis B virus infection on the interferon response in immunodeficient human hepatocyte chimeric mice.
    Tsuge M; Takahashi S; Hiraga N; Fujimoto Y; Zhang Y; Mitsui F; Abe H; Kawaoka T; Imamura M; Ochi H; Hayes CN; Chayama K
    J Infect Dis; 2011 Jul; 204(2):224-8. PubMed ID: 21673032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus sensitizes hepatocytes to complement-dependent cytotoxicity through downregulating CD59.
    Qu Z; Liang X; Liu Y; Du J; Liu S; Sun W
    Mol Immunol; 2009 Dec; 47(2-3):283-9. PubMed ID: 19804910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: transmission experiments to chimeric mice with human liver repopulated hepatocytes.
    Tabuchi A; Tanaka J; Katayama K; Mizui M; Matsukura H; Yugi H; Shimada T; Miyakawa Y; Yoshizawa H
    J Med Virol; 2008 Dec; 80(12):2064-8. PubMed ID: 19040280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver.
    Suslov A; Boldanova T; Wang X; Wieland S; Heim MH
    Gastroenterology; 2018 May; 154(6):1778-1790. PubMed ID: 29408639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice.
    Tsuge M; Hiraga N; Akiyama R; Tanaka S; Matsushita M; Mitsui F; Abe H; Kitamura S; Hatakeyama T; Kimura T; Miki D; Mori N; Imamura M; Takahashi S; Hayes CN; Chayama K
    J Gen Virol; 2010 Jul; 91(Pt 7):1854-64. PubMed ID: 20219897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of chimeric mice with livers repopulated by serially subcultured human hepatocytes to hepatitis B virus.
    Utoh R; Tateno C; Yamasaki C; Hiraga N; Kataoka M; Shimada T; Chayama K; Yoshizato K
    Hepatology; 2008 Feb; 47(2):435-46. PubMed ID: 18098326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent advance in the study of immunopathobiology of hepatitis B virus infection using HBV transgenic mice].
    Kakimi K
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():54-7. PubMed ID: 15453285
    [No Abstract]   [Full Text] [Related]  

  • 8. Upregulation of indoleamine 2,3-dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus-specific cytotoxic T lymphocytes in vivo.
    Iwamoto N; Ito H; Ando K; Ishikawa T; Hara A; Taguchi A; Saito K; Takemura M; Imawari M; Moriwaki H; Seishima M
    Liver Int; 2009 Feb; 29(2):277-83. PubMed ID: 18397228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection.
    Meuleman P; Steyaert S; Libbrecht L; Couvent S; Van Houtte F; Clinckspoor F; de Hemptinne B; Roskams T; Vanlandschoot P; Leroux-Roels G
    Clin Chim Acta; 2006 Apr; 366(1-2):156-62. PubMed ID: 16253217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human microRNA hsa-miR-1231 suppresses hepatitis B virus replication by targeting core mRNA.
    Kohno T; Tsuge M; Murakami E; Hiraga N; Abe H; Miki D; Imamura M; Ochi H; Hayes CN; Chayama K
    J Viral Hepat; 2014; 21(9):e89-97. PubMed ID: 24835118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein profiles in SCID/uPA mice transplanted with human hepatocytes become human-like and correlate with HCV infection success.
    Steenbergen RH; Joyce MA; Lund G; Lewis J; Chen R; Barsby N; Douglas D; Zhu LF; Tyrrell DL; Kneteman NM
    Am J Physiol Gastrointest Liver Physiol; 2010 Oct; 299(4):G844-54. PubMed ID: 20651006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-species transmission of gibbon and orangutan hepatitis B virus to uPA/SCID mice with human hepatocytes.
    Sa-Nguanmoo P; Tanaka Y; Ratanakorn P; Sugiyama M; Murakami S; Payungporn S; Sommanustweechai A; Mizokami M; Poovorawan Y
    Virus Res; 2011 Jun; 158(1-2):209-15. PubMed ID: 21510984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The innate immune response to hepatitis B virus infection: implications for pathogenesis and therapy.
    Chang J; Block TM; Guo JT
    Antiviral Res; 2012 Dec; 96(3):405-13. PubMed ID: 23072881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune control of hepatitis B virus.
    Bauer T; Sprinzl M; Protzer U
    Dig Dis; 2011; 29(4):423-33. PubMed ID: 21894014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice.
    Lütgehetmann M; Bornscheuer T; Volz T; Allweiss L; Bockmann JH; Pollok JM; Lohse AW; Petersen J; Dandri M
    Gastroenterology; 2011 Jun; 140(7):2074-83, 2083.e1-2. PubMed ID: 21376046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus.
    Tsuge M; Hiraga N; Takaishi H; Noguchi C; Oga H; Imamura M; Takahashi S; Iwao E; Fujimoto Y; Ochi H; Chayama K; Tateno C; Yoshizato K
    Hepatology; 2005 Nov; 42(5):1046-54. PubMed ID: 16250045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B Virus Evasion From Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase Sensing in Human Hepatocytes.
    Verrier ER; Yim SA; Heydmann L; El Saghire H; Bach C; Turon-Lagot V; Mailly L; Durand SC; Lucifora J; Durantel D; Pessaux P; Manel N; Hirsch I; Zeisel MB; Pochet N; Schuster C; Baumert TF
    Hepatology; 2018 Nov; 68(5):1695-1709. PubMed ID: 29679386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis.
    Lam WY; Leung KT; Law PT; Lee SM; Chan HL; Fung KP; Ooi VE; Waye MM
    J Cell Biochem; 2006 Mar; 97(4):795-812. PubMed ID: 16237706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.
    Sugiyama M; Tanaka Y; Kurbanov F; Maruyama I; Shimada T; Takahashi S; Shirai T; Hino K; Sakaida I; Mizokami M
    Gastroenterology; 2009 Feb; 136(2):652-62.e3. PubMed ID: 19041311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
    Bihl F; Loggi E; Chisholm JV; Biselli M; Morelli MC; Cursaro C; Terrault NA; Bernardi M; Bertoletti A; Andreone P; Brander C
    Liver Transpl; 2008 Apr; 14(4):478-85. PubMed ID: 18324666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.